Publication Information

{'id': 'https://openalex.org/W2089916413', 'doi': 'https://doi.org/10.2215/cjn.01180307', 'title': 'Titrating Rituximab to Circulating B Cells to Optimize Lymphocytolytic Therapy in Idiopathic Membranous Nephropathy', 'display_name': 'Titrating Rituximab to Circulating B Cells to Optimize Lymphocytolytic Therapy in Idiopathic Membranous Nephropathy', 'publication_year': 2007, 'publication_date': '2007-08-17', 'ids': {'openalex': 'https://openalex.org/W2089916413', 'doi': 'https://doi.org/10.2215/cjn.01180307', 'mag': '2089916413', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/17702725'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.2215/cjn.01180307', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S184267533', 'display_name': 'Clinical Journal of the American Society of Nephrology', 'issn_l': '1555-9041', 'issn': ['1555-9041', '1555-905X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://doi.org/10.2215/cjn.01180307', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5005075162', 'display_name': 'Paolo Cravedi', 'orcid': 'https://orcid.org/0000-0001-7837-0923'}, 'institutions': [{'id': 'https://openalex.org/I19630809', 'display_name': 'Mario Negri Institute for Pharmacological Research', 'ror': 'https://ror.org/05aspc753', 'country_code': 'IT', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I19630809', 'https://openalex.org/I4210110338', 'https://openalex.org/I4210153126']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Paolo Cravedi', 'raw_affiliation_strings': ['Clinical Research Centre for Rare Diseases Aldo e Cele Daccò, Mario Negri Institute for Pharmacological Research,Villa Camozzi, Ranica, Italy.'], 'affiliations': [{'raw_affiliation_string': 'Clinical Research Centre for Rare Diseases Aldo e Cele Daccò, Mario Negri Institute for Pharmacological Research,Villa Camozzi, Ranica, Italy.', 'institution_ids': ['https://openalex.org/I19630809']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5059276594', 'display_name': 'Piero Ruggenenti', 'orcid': 'https://orcid.org/0000-0002-8394-0879'}, 'institutions': [{'id': 'https://openalex.org/I4210108813', 'display_name': 'Azienda Ospedaliero Universitaria Ospedali Riuniti', 'ror': 'https://ror.org/0213f0637', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210108813']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Piero Ruggenenti', 'raw_affiliation_strings': ['Ospedali Riuniti Di Bergamo'], 'affiliations': [{'raw_affiliation_string': 'Ospedali Riuniti Di Bergamo', 'institution_ids': ['https://openalex.org/I4210108813']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006722324', 'display_name': 'Maria Chiara Sghirlanzoni', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210108813', 'display_name': 'Azienda Ospedaliero Universitaria Ospedali Riuniti', 'ror': 'https://ror.org/0213f0637', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210108813']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Maria Chiara Sghirlanzoni', 'raw_affiliation_strings': ['Ospedali Riuniti Di Bergamo'], 'affiliations': [{'raw_affiliation_string': 'Ospedali Riuniti Di Bergamo', 'institution_ids': ['https://openalex.org/I4210108813']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5023556434', 'display_name': 'Giuseppe Remuzzi', 'orcid': 'https://orcid.org/0000-0002-6194-3446'}, 'institutions': [{'id': 'https://openalex.org/I19630809', 'display_name': 'Mario Negri Institute for Pharmacological Research', 'ror': 'https://ror.org/05aspc753', 'country_code': 'IT', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I19630809', 'https://openalex.org/I4210110338', 'https://openalex.org/I4210153126']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Giuseppe Remuzzi', 'raw_affiliation_strings': ['Istituto Di Ricerche Farmacologiche, Mario Negri'], 'affiliations': [{'raw_affiliation_string': 'Istituto Di Ricerche Farmacologiche, Mario Negri', 'institution_ids': ['https://openalex.org/I19630809']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 3.078, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 173, 'citation_normalized_percentile': {'value': 0.94304, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 98, 'max': 99}, 'biblio': {'volume': '2', 'issue': '5', 'first_page': '932', 'last_page': '937'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11029', 'display_name': 'Renal Diseases and Glomerulopathies', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2727', 'display_name': 'Nephrology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11029', 'display_name': 'Renal Diseases and Glomerulopathies', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2727', 'display_name': 'Nephrology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9979, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10993', 'display_name': 'Complement system in diseases', 'score': 0.9949, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/membranous-nephropathy', 'display_name': 'Membranous Nephropathy', 'score': 0.8300755}, {'id': 'https://openalex.org/keywords/regimen', 'display_name': 'Regimen', 'score': 0.60642606}, {'id': 'https://openalex.org/keywords/single-center', 'display_name': 'Single Center', 'score': 0.5019908}], 'concepts': [{'id': 'https://openalex.org/C2780653079', 'wikidata': 'https://www.wikidata.org/wiki/Q412323', 'display_name': 'Rituximab', 'level': 3, 'score': 0.9463965}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9308021}, {'id': 'https://openalex.org/C2775946357', 'wikidata': 'https://www.wikidata.org/wiki/Q1713037', 'display_name': 'Membranous nephropathy', 'level': 4, 'score': 0.8300755}, {'id': 'https://openalex.org/C18031839', 'wikidata': 'https://www.wikidata.org/wiki/Q5009796', 'display_name': 'CD20', 'level': 3, 'score': 0.61886907}, {'id': 'https://openalex.org/C2781413609', 'wikidata': 'https://www.wikidata.org/wiki/Q7308373', 'display_name': 'Regimen', 'level': 2, 'score': 0.60642606}, {'id': 'https://openalex.org/C2778930706', 'wikidata': 'https://www.wikidata.org/wiki/Q504790', 'display_name': 'Nephrotic syndrome', 'level': 2, 'score': 0.57911897}, {'id': 'https://openalex.org/C2780073493', 'wikidata': 'https://www.wikidata.org/wiki/Q7523837', 'display_name': 'Single Center', 'level': 2, 'score': 0.5019908}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.4912979}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.44955242}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.4491706}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.42892542}, {'id': 'https://openalex.org/C2780368995', 'wikidata': 'https://www.wikidata.org/wiki/Q605006', 'display_name': 'Glomerulonephritis', 'level': 3, 'score': 0.27478486}, {'id': 'https://openalex.org/C159654299', 'wikidata': 'https://www.wikidata.org/wiki/Q79460', 'display_name': 'Antibody', 'level': 2, 'score': 0.26830792}, {'id': 'https://openalex.org/C2780091579', 'wikidata': 'https://www.wikidata.org/wiki/Q9377', 'display_name': 'Kidney', 'level': 2, 'score': 0.10850862}], 'mesh': [{'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D001402', 'descriptor_name': 'B-Lymphocytes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D015433', 'descriptor_name': 'Glomerulonephritis, Membranous', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': True}, {'descriptor_ui': 'D015433', 'descriptor_name': 'Glomerulonephritis, Membranous', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D007155', 'descriptor_name': 'Immunologic Factors', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D008212', 'descriptor_name': 'Lymphocyte Depletion', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': True}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D058846', 'descriptor_name': 'Antibodies, Monoclonal, Murine-Derived', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015331', 'descriptor_name': 'Cohort Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015433', 'descriptor_name': 'Glomerulonephritis, Membranous', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007155', 'descriptor_name': 'Immunologic Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008212', 'descriptor_name': 'Lymphocyte Depletion', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000069283', 'descriptor_name': 'Rituximab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 3, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.2215/cjn.01180307', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S184267533', 'display_name': 'Clinical Journal of the American Society of Nephrology', 'issn_l': '1555-9041', 'issn': ['1555-9041', '1555-905X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://journals.lww.com/cjasn/fulltext/2007/09000/titrating_rituximab_to_circulating_b_cells_to.12.aspx', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/17702725', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.2215/cjn.01180307', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S184267533', 'display_name': 'Clinical Journal of the American Society of Nephrology', 'issn_l': '1555-9041', 'issn': ['1555-9041', '1555-905X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.78}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 21, 'referenced_works': ['https://openalex.org/W1915689252', 'https://openalex.org/W1970626700', 'https://openalex.org/W1979336667', 'https://openalex.org/W1999805116', 'https://openalex.org/W2006132026', 'https://openalex.org/W2018680608', 'https://openalex.org/W2041927193', 'https://openalex.org/W2051266349', 'https://openalex.org/W2051679452', 'https://openalex.org/W2057490818', 'https://openalex.org/W2065940081', 'https://openalex.org/W2089016290', 'https://openalex.org/W2107002794', 'https://openalex.org/W2111892488', 'https://openalex.org/W2115472834', 'https://openalex.org/W2118994799', 'https://openalex.org/W2122507029', 'https://openalex.org/W2141139539', 'https://openalex.org/W2141219630', 'https://openalex.org/W2148920525', 'https://openalex.org/W2326202408'], 'related_works': ['https://openalex.org/W4381306438', 'https://openalex.org/W3116220978', 'https://openalex.org/W2767084559', 'https://openalex.org/W2126167931', 'https://openalex.org/W2049439131', 'https://openalex.org/W2039226259', 'https://openalex.org/W2017866273', 'https://openalex.org/W1969480819', 'https://openalex.org/W1966718538', 'https://openalex.org/W1550877063'], 'abstract_inverted_index': {'Background': [0], 'and': [1, 17, 21, 32, 53, 81, 84, 137, 165, 170, 177, 210, 240, 256], 'Objectives:': [2], 'Rituximab,': [3], 'given': [4, 101], 'in': [5, 149, 158, 227], 'four': [6, 106], 'weekly': [7, 107], 'doses,': [8], 'is': [9, 33, 216, 237], 'a': [10, 64, 86, 117, 188], 'promising': [11], 'treatment': [12, 89, 164, 205], 'for': [13, 162, 221, 253], 'idiopathic': [14, 78, 211], 'membranous': [15, 79, 212], 'nephropathy': [16, 80, 213], 'other': [18], 'immune-mediated': [19], 'diseases': [20], 'lymphoproliferative': [22], 'disorders.': [23], 'This': [24, 36], 'multidose': [25], 'regimen,': [26], 'however,': [27], 'may': [28, 50, 241, 249], 'cause': [29], 'hypersensitivity': [30], 'reactions': [31, 255], 'extremely': [34, 238], 'expensive.': [35], 'study': [37], 'was': [38, 90, 147, 156], 'aimed': [39], 'at': [40, 192], 'evaluating': [41], 'whether': [42], 'titrating': [43], 'rituximab': [44, 163, 194, 204, 236], 'to': [45, 120, 235], 'circulating': [46], 'CD20': [47, 123, 153], 'B': [48, 87, 175, 197, 207], 'cells': [49], 'improve': [51], 'safety': [52], 'limit': [54, 242], 'costs': [55], 'of': [56, 71, 94, 105, 109, 131, 134, 140, 245, 259], 'treatment.': [57], 'Design,': [58], 'Setting,': [59], 'Participants,': [60], '&': [61], 'Measurements:': [62], 'In': [63], 'matched-cohort,': [65], 'single-center,': [66], 'controlled': [67], 'study,': [68], 'the': [69, 102, 132, 138, 174, 178, 243, 251], 'outcome': [70], '12': [72], 'new': [73], 'incident': [74], 'patients': [75, 98, 141], 'who': [76, 99, 142], 'had': [77, 187], 'nephrotic': [82, 135], 'syndrome': [83, 136], 'received': [85], 'cell–driven': [88, 176], 'compared': [91], 'with': [92, 173], 'that': [93, 248], '24': [95], 'historical': [96], 'reference': [97], 'were': [100], 'standard': [103, 185, 203], 'protocol': [104, 186], 'doses': [108], '375': [110], 'mg/m2.': [111], 'Results:': [112], 'Only': [113], 'one': [114], 'patient': [115, 183], 'needed': [116], 'second': [118, 193], 'dose': [119], 'achieve': [121], 'full': [122], 'cell': [124, 154, 198, 208], 'depletion.': [125], 'At': [126], '1': [127], 'yr,': [128], 'time': [129], 'course': [130], 'components': [133], 'proportion': [139], 'achieved': [143, 157], 'disease': [144, 260], 'remission': [145, 214], '(25%)': [146], 'identical': [148], 'both': [150], 'groups.': [151], 'Persistent': [152], 'depletion': [155, 209], 'all': [159], 'patients.': [160], 'Costs': [161], 'hospitalizations': [166], 'totalled': [167], '€3770.90': [168], '($4902.20)': [169], '€13,977.60': [171], '($18,170.80)': [172], 'four-dose': [179], 'protocol,': [180], 'respectively.': [181], 'One': [182], 'on': [184], 'severe': [189], 'adverse': [190, 254], 'reaction': [191], 'dose.': [195], 'Thus,': [196], 'titrated': [199], 'as': [200, 202], 'effectively': [201], 'achieves': [206], 'but': [215], 'fourfold': [217], 'less': [218], 'expensive,': [219], 'allowing': [220], 'more': [222], 'than': [223], '€10,000,': [224], 'approximately': [225], '$13,000': [226], 'savings': [228], 'per': [229], 'patient.': [230], 'Conclusions:': [231], 'Avoiding': [232], 'unnecessary': [233], 'reexposure': [234], 'cost-saving': [239], 'production': [244], 'antichimeric': [246], 'antibodies': [247], 'increase': [250], 'risk': [252], 'prevent': [257], 're-treatment': [258], 'recurrences.': [261]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2089916413', 'counts_by_year': [{'year': 2024, 'cited_by_count': 11}, {'year': 2023, 'cited_by_count': 13}, {'year': 2022, 'cited_by_count': 10}, {'year': 2021, 'cited_by_count': 11}, {'year': 2020, 'cited_by_count': 16}, {'year': 2019, 'cited_by_count': 5}, {'year': 2018, 'cited_by_count': 7}, {'year': 2017, 'cited_by_count': 15}, {'year': 2016, 'cited_by_count': 14}, {'year': 2015, 'cited_by_count': 11}, {'year': 2014, 'cited_by_count': 11}, {'year': 2013, 'cited_by_count': 12}, {'year': 2012, 'cited_by_count': 8}], 'updated_date': '2024-12-23T14:31:53.363433', 'created_date': '2016-06-24'}